From the Cytoplasm into the Nucleus—Hepatitis B Virus Travel and Genome Repair by Johan Ringlander, Gustaf E. Rydell, Michael Kann

Subjects: “…hepatitis B virus…”
Get full text

Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque by Tingfu Du, Shuaiyao Lu, Qinfang Jiang, Yun Li, Kaili Ma

“…This study is the first to explore genome-wide protein expression in hepatic tissue of diabetes macaque model using HPLC-Q-TOF/MS technology. …”
Get full text

Pegilated interferon α2а in treatment of chronic hepatitis C by P. O. Bogomolov, S. V. Koblov, A. O. Buyeverov, M. V. Matsiyevich, O. S. Kuzmina, N. A. Barsukova, N. V. Dubinina

Subjects: “…chronic hepatitis c…”
Get full text

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B by K. R. Dudina, O. O. Znoyko

Subjects: “…acute hepatitis b…”
Get full text

Hepatic Kaposi Sarcoma after Kidney Transplantation: A Case Report by Seunghyeon Roh, Myoung Seok Lee, Siwon Jang, Min Hoan Moon, Joon Koo Han

“…We report a rare case of de novo hepatic Kaposi’s sarcoma manifesting as an ill-defined infiltrative lesion in the left lobe of the liver in a patient who was immunosuppressed for 9 months after a kidney transplantation using ultrasonography, CT, MRI, and fluorodeoxyglucose-PET.…”
Get full text

Risk Factors for Hepatitis C Virus Transmission Obscure in Nigerian Patients by Olive Obienu, Sylvester Nwokediuko, Abraham Malu, Olufunmilayo A. Lesi

Get full text

HAART and Liver: A Discussion of Hepatic Disease in those Living with HIV by Curtis Cooper, Paul C Adams

Get full text

Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection by Andrea Magri, Giulia Francesca Manfredi, Carlo Smirne, Silvia Pigni, Michela Emma Burlone, Mattia Bellan, Nicole Vercellino, Rosalba Minisini, Mario Pirisi

Subjects: “…hepatitis C…”
Get full text

Achieving chronic hepatitis B functional cure: Factors and potential mechanisms by Jiarui Zheng, Zilong Wang, Linxiang Huang, Zixuan Qiu, Yandi Xie, Suzhen Jiang, Bo Feng

“…Chronic hepatitis B (CHB) is a significant global health issue affecting approximately 254 million individuals worldwide. …”
Get full text

Hepatitis C Infection and Periodontal Disease: Is there a Common Immunological Link? by Dorin Nicolae Gheorghe, Liliana Foia, Vasilica Toma, Amelia Surdu, Elena Herascu, Dora Maria Popescu, Petra Surlin, Cristin Constantin Vere, Ion Rogoveanu

“…Hepatitis C virus (HCV) infections could have an important impact on the oral health status of patients, favoring conditions such as periodontal disease and oral cancer. …”
Get full text

Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation by Edith Villeneuve, Jean Vincelette, Jean-Pierre Villeneuve

“…Cirrhotic patients who undergo liver transplantation are at risk of acquiring de novo hepatitis B virus (HBV) infection at the time of transplantation. …”
Get full text

The burden of hepatitis E virus infection among Ghanaian pregnant women by Husein Bagulo, Husein Bagulo, Ayodele O. Majekodunmi, Ayodele O. Majekodunmi, Susan C. Welburn, Susan C. Welburn, Langbong Bimi

Subjects: “…hepatitis E virus (HEV)…”
Get full text

Hepatocellular Carcinoma Masquerading as a Large Renal Mass with Hepatic Invasion by Joseph R. N. Zabell, Kenneth G. Nepple, Neal W. Wilkinson, Laila Dahmoush, Richard D. Williams

“…A diagnosis of chronic hepatitis B was made postoperatively. Primary hepatocellular carcinoma with direct renal extension is an exceedingly rare occurrence based on our experience and review of the published literature.…”
Get full text

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B by I. G. Bakulin

“…To estimate safety and efficacy of prescription of nucleoside analogues the patient with liver cirrhosis in an outcome of chronic hepatitis B.Original positions of the report. Rates of progression of persistent HBV infection to liver cirrhosis stage depend on several factors – spectrum of viral markers, immune status of the patient, his/her age, gender, genetic predisposition, etc. …”
Get full text

Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection by Poupak Fallahi, Silvia Martina Ferrari, Ugo Politti, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli

“…Frequently, patients with hepatitis C virus (HCV) chronic infection have high levels of serum anti-thyroperoxidase and/or anti-thyroglobulin autoantibodies, ultrasonographic signs of chronic autoimmune thyroiditis, and subclinical hypothyroidism, in female gender versus healthy controls, or hepatitis B virus infected patients. …”
Get full text

Comment on: “Hepatitis C Virus in Arab World: A State of Concern” by Gasim I. Gasim

Get full text

Giant Hepatic Carcinoid: A Rare Tumor with a Favorable Prognosis by Serge Landen, Maxime Elens, Celine Vrancken, Frederiek Nuytens, Thibault Meert, Veronique Delugeau

“…Primary hepatic carcinoids are rare tumors that are often diagnosed at a locally advanced stage. …”
Get full text

The Role of Serum Cytokines in the Pathogenesis of Hepatic Osteodystrophy in Male Cirrhotic Patients by Ali Riza Soylu, Cengiz Tuglu, Ender Arikan, Tarkan Yetisyigit, Hakan Kunduracılar, Ibrahim Hakki Koker, Gulbin Unsal, Ahmet Huseyin Tezel, Hasan Umit, Sakir Berkarda

“…In this study, we aimed to investigate the possible role of serum cytokines in the development of hepatic osteodystrophy. Matherial and Methods. 44 consecutive male cirrhotic patients (17 alcoholic, 20 hepatitis B, 7 hepatitis C), 15 age- and sex-matched chronic alcoholics without liver disease, and 17 age- and sex-matched healthy controls were included in the study during one year period. …”
Get full text

Response to: Comment on “Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation” by Yi Shen, Li Yang

Get full text

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV by Diwakar Davar, Melissa Wilson, Chelsea Pruckner, John M. Kirkwood

“…Given hypothesized risk of triggering exacerbations of autoimmune diseases and/or chronic viral infections, clinical trials (including regulatory studies) evaluating checkpoint blocking antibodies PD-1 and CTLA-4 have excluded patients with autoimmune diseases, chronic hepatitis B/C virus (HBV/HCV), and/or human immunodeficiency virus (HIV) infections. …”
Get full text